Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Distance From a Transplant Center is associated with receipt of liver transplant and survival

This week's issue of the Journal of the American Medical Association examines the association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.

News image

Importance  Centralization of specialized health care services such as organ transplantation and bariatric surgery is advocated to improve quality, increase efficiency, and reduce cost.

The effect of increased travel on access and outcomes from these services is not fully understood.

Dr David Goldberg and colleagues from Philadelphia, USA evaluated the association between distance from a Veterans Affairs (VA) transplant center (VATC) and access to being waitlisted for liver transplantation, actually having a liver transplant, and mortality.

The team performed a retrospective study of veterans meeting liver transplantation eligibility criteria from 2003 until 2010, using data from the Veterans Health Administrationís integrated, national, electronic medical record linked to Organ Procurement and Transplantation Network data.

The team's primary outcome was being waitlisted for transplantation at a VATC.

Secondary outcomes included being waitlisted at any transplant center, undergoing a transplantation, and survival.

From 2003-2010, 50,637 veterans were classified as potentially eligible for transplant.

11% were waitlisted at any transplant center
Journal of the American Medical Association

The team noted that 6% were waitlisted and 49% of those were waitlisted at 1 of the 5 VATCs.

Of 3417 veterans receiving care at a VA hospital located within 100 miles from a VATC,

The team observed that 7% were waitlisted at a VATC, and 11% at any transplant center.

Of 47,219 veterans receiving care at a VA hospital located more than 100 miles from a VATC, 3% were waitlisted at a VATC, and 5% at any transplant center.

In multivariable models, the researchers found that increasing distance to closest VATC was associated with significantly lower odds of being waitlisted at a VATC or any transplant center.

For example, the researchers found that a veteran living 25 miles from a VATC would have a 7% adjusted probability of being waitlisted, whereas a veteran 100 miles from a VATC would have a 6% adjusted probability.

In adjusted models, increasing distance from a VATC was associated with significantly lower transplantation rates.

The researchers found a significantly increased mortality among waitlisted veterans from the time of first hepatic decompensation event in multivariable survival models.

For example, a waitlisted veteran living 25 miles from a VATC would have a 63% 5-year adjusted probability of survival from first hepatic decompensation event compared with a 60% 5-year adjusted probability of survival for a veteran living 100 miles from a VATC.

Dr Goldberg and team conclude, "Among VA patients meeting eligibility criteria for liver transplantation, greater distance from a VATC or any transplant center was associated with lower likelihood of being waitlisted, receiving a liver transplant, and greater likelihood of death."

"The relationship between these findings and centralizing specialized care deserves further investigation."

JAMA 2014; 311(12): 1234-1243
28 March 2014

Go to top of page Email this page Email this page to a colleague

 01 March 2015

Advanced search
 27 February 2015 
Obesity and weight-loss therapy
 27 February 2015 
MRE performance in staging liver fibrosis
 27 February 2015 
Bleeding in diverticulosis
 26 February 2015 
Familial colorectal cancer risk and primary cancer
 26 February 2015 
Questionnaires for GERD
 26 February 2015 
Herbal products and the liver
 25 February 2015 
Exercise and NAFLD
 25 February 2015 
IBD in Korea
 25 February 2015 
Immunosuppressive therapy and T. whipplei
 24 February 2015 
Clinical trials in pediatric IBD
 24 February 2015 
Reducing health care costs in IBD
 24 February 2015 
GI bleeding after anticoagulation interruption
 23 February 2015 
Visceral abdominal obesity and IBS
 23 February 2015 
Crohn's outcomes with infliximab
 23 February 2015 
Intestinal microbiota and celiac disease
 20 February 2015 
H. pylori eradication
 20 February 2015 
Antiviral treatment and Hep C outcomes
 20 February 2015 
C. diff testing in IBD
 19 February 2015 
Intestinal microbiota in IBS
 19 February 2015 
Peptic ulcer bleeding mortality in liver disease
 19 February 2015 
Fecal microbial transplant in active Crohn's disease
 18 February 2015 
Genetic testing and GI cancers
 18 February 2015 
Placebo analgesia in functional abdominal pain
 18 February 2015 
Successful Hep C virus therapy
 17 February 2015 
Quality measures and colonoscopist selection
 17 February 2015 
Global incidence of esophageal cancer
 17 February 2015 
Anti-viral treatment and survival in Hep C
 16 February 2015 
Saliva for the diagnosis of GERD
 16 February 2015 
H pylori eradication therapy
 16 February 2015 
Medical marijuana for digestive disorders
 13 February 2015 
Beta-blockers in cirrhosis
 13 February 2015 
Liver disease and peptic ulcer bleeding
 13 February 2015 
Prevalence of microscopic colitis
 12 February 2015 
Liver disease in chronic Hep C
 12 February 2015 
Patient-reported outcomes in Hep C
 12 February 2015 
Patientsí colonoscopist selection
 11 February 2015 
NAFLD and CVD
 11 February 2015 
Guidelines for the diagnosis of hepatocellular carcinoma
 11 February 2015 
Hepatic decompensation in Hep C cirrhosis
 10 February 2015 
Percutaneous endoscopic gastrostomy
 10 February 2015 
Factors that influence hepatic steatosis
 10 February 2015 
Gene variants and Crohn's susceptibility
 09 February 2015 
Factors that influence gallstone surgery
 09 February 2015 
Factors associated with increased mortality in cirrhosis
 09 February 2015 
Use of immunomodulators in IBD
 06 February 2015 
Colorectal cancer risk in IBD
 06 February 2015 
H. pylori and peptic ulcer bleeding
 06 February 2015 
IBS and somatization
 05 February 2015 
GERD, dyspepsia and IBS symptoms
 05 February 2015 
Quality of life in Crohn's after antitumor necrosis factor agents
 05 February 2015 
Thalidomide and refractory Crohn's
 04 February 2015 
Telemedicine in IBD
 04 February 2015 
Infliximab and muscle wasting in Crohn's
 04 February 2015 
Resistance mutations in chronic Hep B
 03 February 2015 
Testosterone in advanced liver disease
 03 February 2015 
Mortality in peptic ulcer bleeding
 03 February 2015 
Colonoscopic remission of ulcerative colitis
 02 February 2015 
Colonoscopy and colon cancer risk in IBD
 02 February 2015 
Sirolimus in Hep C virus infected liver graft recipients
 02 February 2015 
Treatment of C. diff in adults

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us